http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2491086-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate | 2008-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e56672bb9941c3929e771662f2e0fc4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93ca311b6ac4063b3fcadb24d8e0bd2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c5940ab6406f3fe914c7b9165705aed |
| publicationDate | 2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2491086-C2 |
| titleOfInvention | Method of treating urinogenital neurological disorders with using modified clostridial toxins |
| abstract | FIELD: medicine. n SUBSTANCE: group of inventions refers to methods of treating urinogenital neurological disorders with using drug preparations containing a modified clostridial toxin, and using modified clostridial toxins in preparing drug preparations for treating the urinogenital neurological disorders. The methods of treating the urinogenital neurological disorders involve the stage of administering a therapeutically effective amount of a composition containing the modified clostridial toxin into a mammal in need thereof. n EFFECT: group of inventions is characterised by the effective treatment of the urinogenital neurological disorders and minimal effects in the regions being other than the goals of the toxin therapy. n 15 cl, 11 dwg, 2 tbl, 11 ex |
| priorityDate | 2007-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.